Back to User profile » Professor Yuebing Wu
Paper published by Professor Yuebing Wu:
Original Research
The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
Li X, Wu D, Tang J, Wu Y
Cancer Management and Research 2024, 16:1003-1012
Published Date: 8 August 2024